Feasibility and utility of re-treatment with (177)Lu-DOTATATE in GEP-NENs relapsed after treatment with (90)Y-DOTATOC (Q85472073)

From Wikidata

Jump to navigation Jump to search

scientific article published on 26 June 2015

edit

Language	Label	Description	Also known as
English	Feasibility and utility of re-treatment with (177)Lu-DOTATATE in GEP-NENs relapsed after treatment with (90)Y-DOTATOC	scientific article published on 26 June 2015

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26112388

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112388%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 February 2020

title

Feasibility and utility of re-treatment with (177)Lu-DOTATATE in GEP-NENs relapsed after treatment with (90)Y-DOTATOC (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26112388

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112388%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 February 2020

main subject

lutetium-177

1 reference

based on heuristic

inferred from title

author

Toni Ibrahim

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26112388

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112388%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 February 2020

Giovanni Paganelli

series ordinal

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26112388

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112388%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 February 2020

Lisa Bodei

series ordinal

4

object named as

Lisa Bodei

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26112388

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112388%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 February 2020

Stefano Severi

series ordinal

1

object named as

Stefano Severi

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26112388

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112388%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 February 2020

author name string

Maddalena Sansovini

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26112388

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112388%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 February 2020

Annarita Ianniello

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26112388

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112388%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 February 2020

Silvia Nicolini

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26112388

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112388%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 February 2020

Valentina Di Iorio

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26112388

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112388%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 February 2020

Vincenzo D'Errico

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26112388

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112388%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 February 2020

Paola Caroli

series ordinal

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26112388

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112388%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 February 2020

Manuela Monti

series ordinal

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26112388

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112388%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 February 2020

publication date

26 June 2015

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26112388

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112388%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 February 2020

published in

European Journal of Nuclear Medicine and Molecular Imaging

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26112388

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112388%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 February 2020

volume

42

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26112388

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112388%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 February 2020

issue

13

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26112388

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112388%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 February 2020

page(s)

1955-1963

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26112388

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112388%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 February 2020

cites work

Predictors of long-term outcome in patients with well-differentiated gastroenteropancreatic neuroendocrine tumors after peptide receptor radionuclide therapy with 177Lu-octreotate.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26112388

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26112388

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New advances in peptide receptor radionuclide therapy.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26112388

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

18F-fluorodeoxyglucose positron emission tomography predicts survival of patients with neuroendocrine tumors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26112388

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic variables in patients with gastrointestinal carcinoid tumours

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26112388

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Receptor radionuclide therapy with 90Y-[DOTA]0-Tyr3-octreotide (90Y-DOTATOC) in neuroendocrine tumours

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26112388

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26112388

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

GEPNETs update: Radionuclide therapy in neuroendocrine tumors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26112388

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26112388

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26112388

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The ENETS guidelines: the new TNM classification system

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26112388

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment with the radiolabelled somatostatin analog Lu-DOTATATE for advanced pancreatic neuroendocrine tumors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26112388

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

68Ga-DOTANOC PET/CT clinical impact in patients with neuroendocrine tumors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26112388

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Repeated cycles of peptide receptor radionuclide therapy (PRRT) – Results and side-effects of the radioisotope 90Y-DOTA TATE, 177Lu-DOTA TATE or 90Y/177Lu-DOTA TATE therapy in patients with disseminated NET

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26112388

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26112388

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of 18FDG PET/CT in patients treated with 177Lu-DOTATATE for advanced differentiated neuroendocrine tumours.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26112388

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patient selection for personalized peptide receptor radionuclide therapy using Ga-68 somatostatin receptor PET/CT.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26112388

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular Imaging Radiotherapy: Theranostics for Personalized Patient Management of Neuroendocrine Tumors (NETs).

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26112388

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome of peptide receptor radionuclide therapy with 177Lu-octreotate in advanced grade 1/2 pancreatic neuroendocrine tumours

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26112388

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peptide receptor radionuclide therapy for neuroendocrine tumors in Germany: first results of a multi-institutional cancer registry

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26112388

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuroendocrine tumors. Peptide receptor radionuclide therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26112388

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Yttrium-labelled peptides for therapy of NET.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26112388

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

177 Lu-Dota-octreotate radionuclide therapy of advanced gastrointestinal neuroendocrine tumors: results from a phase II study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26112388

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome and toxicity of salvage therapy with 177Lu-octreotate in patients with metastatic gastroenteropancreatic neuroendocrine tumours

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26112388

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors in gastrointestinal endocrine tumors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26112388

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recommendations for management of patients with neuroendocrine liver metastases

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26112388

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26112388

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment with 177Lu-DOTATOC of patients with relapse of neuroendocrine tumors after treatment with 90Y-DOTATOC.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26112388

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26112388

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Individualized peptide-related-radionuclide-therapy concept using different radiolabelled somatostatin analogs in advanced cancer patients.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26112388

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

D-lysine reduction of indium-111 octreotide and yttrium-90 octreotide renal uptake

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26112388

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response, survival, and long-term toxicity after therapy with the radiolabeled somatostatin analogue [90Y-DOTA]-TOC in metastasized neuroendocrine cancers

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26112388

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How smart is peptide receptor radionuclide therapy of neuroendocrine tumors especially in the salvage setting? The clinician's perspective.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26112388

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26112388

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term hematotoxicity after peptide receptor radionuclide therapy with 177Lu-octreotate

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26112388

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peptide receptor radionuclide therapy with ¹⁷⁷Lu-DOTATATE: the IEO phase I-II study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26112388

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salvage therapy with (177)Lu-octreotate in patients with bronchial and gastroenteropancreatic neuroendocrine tumors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26112388

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26112388

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multianalyte PCR blood test outperforms single analyte ELISAs (chromogranin A, pancreastatin, neurokinin A) for neuroendocrine tumor detection.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26112388

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S00259-015-3105-7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26112388

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112388%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 February 2020

Dimensions Publication ID

1027734738

0 references

PubMed publication ID

26112388

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26112388

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112388%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 February 2020

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q85472073&oldid=2249129465"